AuBiotech CEO Lorraine Chiroiu says the sector is very concerned by the decision to waive intellectual property protection for COVID-19 vaccines and treatments given what it says about the lack of understanding of its importance in attracting investment that ultimately supports innovation. …
AusBiotech's Lorraine Chiroiu: A 'hollow victory' and 'slap in the face'
July 18, 2022 Latest NewsBioPharmaAustralian BiotechBioPharmaDispatch ExecutiveNews of the Day
Latest Video
New Stories
-
Australia’s life sciences sector emerges as fast growing, globally connected powerhouse
May 21, 2026 - - Latest News -
They used to forecast growth, it was not real and couldn't be used, and it made the program a target for cuts
May 21, 2026 - - Latest News -
New report reveals how AI is now deciding which healthcare brands Australians see online
May 21, 2026 - - Latest News -
Medicine shortages and workforce gaps threaten the sustainability of Australian care
May 21, 2026 - - Latest News -
Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS
May 20, 2026 - - Latest News -
Owen Smith: 'We are ready to negotiate. We are ready to be a genuine partner'
May 19, 2026 - - Latest News -
Australia bets on translational science to turn discovery into global impact
May 19, 2026 - - Latest News